Gilles A. Salles

Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis.

G. Salles, B. Coiffier, M. Ghielmini, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.

E. Hoster, P. Feugier, H. Tilly, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel

M. Kersten, G. Salles, U. Jaeger, 2019, Blood.